Terms: = Kidney tumors AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA AND Diagnosis
173 results:
1. A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
Tsukita H; Koyama K; Ishinari T; Takahashi A; Miyabe K; Umakoshi M; Yoshida M; Kudo-Asabe Y; Nishida A; Otsuka N; Yasui O; Kato I; Fukushima N; Goto A
Diagn Pathol; 2024 Apr; 19(1):59. PubMed ID: 38622713
[TBL] [Abstract] [Full Text] [Related]
2. Cystic Features in Renal Epithelial Neoplasms and Their Increasing Clinical and Pathologic Significance.
Tretiakova M; Kwon JW; Paner GP
Adv Anat Pathol; 2024 May; 31(3):157-168. PubMed ID: 38525552
[TBL] [Abstract] [Full Text] [Related]
3. A nomogram based on tfe3 IHC results and clinical factors as a preliminary screening scheme for tfe3-rearranged renal cell carcinoma.
Li P; Xu Q; Chen M; Zhu J; Wang Y; Mumin MA; Huang K; Jiang Z; Liang H; Deng Q; Wang Z; Liao B; Chen W; Cao Y; Cao J; Luo J
Cancer Med; 2024 Mar; 13(5):e6813. PubMed ID: 38477529
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
Taylor AS; Mannan R; Pantanowitz L; Chinnaiyan AM; Dhanasekaran SM; Hrycaj S; Cao X; Chan MP; Lucas D; Wang XM; Mehra R
Med Oncol; 2024 Feb; 41(3):76. PubMed ID: 38393424
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic strategies and predictive models for Xp11.2 translocation/tfe3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers.
Yang Y; Zhao C; Wang Z; Liu F; Zhao M; Yang H; Chen J; Chen X; Shi M; Jiang D; Luo X; Duan Y; Bai Y
Aging (Albany NY); 2024 Jan; 16(2):1696-1711. PubMed ID: 38261736
[TBL] [Abstract] [Full Text] [Related]
6. Genomic alterations and diagnosis of renal cancer.
Zhang X; Bolck HA; Rupp NJ; Moch H
Virchows Arch; 2024 Feb; 484(2):323-337. PubMed ID: 37999735
[TBL] [Abstract] [Full Text] [Related]
7. Lessons from 801 clinical tfe3/TFEB fluorescence in situ hybridization assays performed on renal cell carcinoma suspicious for MiTF family aberrations.
Wang XM; Shao L; Xiao H; Myers JL; Pantanowitz L; Skala SL; Udager AM; Vaishampayan U; Mannan R; Dhanasekaran SM; Chinnaiyan AM; Betz BL; Brown N; Mehra R
Am J Clin Pathol; 2023 Dec; 160(6):549-554. PubMed ID: 37499055
[TBL] [Abstract] [Full Text] [Related]
8. High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinoma.
Lang M; Schmidt LS; Wilson KM; Ricketts CJ; Sourbier C; Vocke CD; Wei D; Crooks DR; Yang Y; Gibbs BK; Zhang X; Klumpp-Thomas C; Chen L; Guha R; Ferrer M; McKnight C; Itkin Z; Wangsa D; Wangsa D; James A; Difilippantonio S; Karim B; Morís F; Ried T; Merino MJ; Srinivasan R; Thomas CJ; Linehan WM
J Exp Clin Cancer Res; 2023 Apr; 42(1):99. PubMed ID: 37095531
[TBL] [Abstract] [Full Text] [Related]
9. Ossifying Fibromyxoid Tumor of the Genitourinary Tract: Report of 4 Molecularly Confirmed Cases of a Diagnostic Pitfall.
Argani P; Dickson BC; Gross JM; Matoso A; Baraban E; Antonescu CR
Am J Surg Pathol; 2023 Jun; 47(6):709-716. PubMed ID: 37026814
[TBL] [Abstract] [Full Text] [Related]
10. Cystic MED15::tfe3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature.
Doytcheva K; Gallan AJ; Wang P; Wanjari P; Segal J; Antic T
Hum Pathol; 2023 Jun; 136():25-33. PubMed ID: 36997032
[TBL] [Abstract] [Full Text] [Related]
11. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
[No Abstract] [Full Text] [Related]
12. A case report and literature review on nephrogenic alveolar soft part sarcoma: clinicopathological manifestations and genetic features.
Wang X; Yu J; Fan X; Ma S; Xie X; Gao N; Huang S; Lu A
BMC Urol; 2023 Feb; 23(1):17. PubMed ID: 36782230
[TBL] [Abstract] [Full Text] [Related]
13. MiT/TFE Family Renal Cell Carcinoma.
Tang J; Baba M
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672892
[TBL] [Abstract] [Full Text] [Related]
14. A case of tfe3 translocation renal cell carcinoma with rare morphological features and literature review.
Xia T; Long H; Liao D; Wang W; Xiao X
Indian J Pathol Microbiol; 2023; 66(1):135-140. PubMed ID: 36656224
[TBL] [Abstract] [Full Text] [Related]
15.
Argani P; Matoso A; Baraban EG; Epstein JI; Antonescu CR
Int J Surg Pathol; 2023 Jun; 31(4):409-414. PubMed ID: 36591911
[TBL] [Abstract] [Full Text] [Related]
16. Clear cell renal cell carcinoma with focal psammomatous calcifications: a rare occurrence mimicking translocation carcinoma.
Sangoi AR; Al-Obaidy KI; Cheng L; Kao CS; Chan E; Sadasivan S; Levin AM; Alvarado-Cabrero I; Kunju LP; Mehra R; Mannan R; Wang X; Dhillon J; Tretiakova M; Smith SC; Hes O; Williamson SR
Histopathology; 2023 Apr; 82(5):684-690. PubMed ID: 36564980
[TBL] [Abstract] [Full Text] [Related]
17. New insights in the new WHO classification of adult renal tumors.
Hes O; Michalová K; Pivovarčíková K
Cesk Patol; 2022; 67(4):187-191. PubMed ID: 36513503
[TBL] [Abstract] [Full Text] [Related]
18. Application of tfe3 Immunophenotypic and tfe3 mRNA Expressions in diagnosis and Prognostication of Adrenal Cortical Neoplasms and Distinction From kidney tumors.
Wang X; Ng CS; Yin W; Liang L
Appl Immunohistochem Mol Morphol; 2023 Jan; 31(1):9-16. PubMed ID: 36476598
[TBL] [Abstract] [Full Text] [Related]
19. tfe3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms.
Caliò A; Marletta S; Brunelli M; Pedron S; Portillo SC; Segala D; Bariani E; Gobbo S; Netto G; Martignoni G
Virchows Arch; 2022 Dec; 481(6):877-891. PubMed ID: 35980471
[TBL] [Abstract] [Full Text] [Related]
20. Minimally invasive cytologic evaluation leading to the diagnosis of tfe3-rearranged renal cell carcinoma: A case report.
Gama A; Sukhanova M; Choy B
Diagn Cytopathol; 2022 Dec; 50(12):E382-E385. PubMed ID: 35975764
[TBL] [Abstract] [Full Text] [Related]
[Next]
